Califf Sits Down For Fireside Chat; Looks Back And Ahead

Robert Califf marked his one-year anniversary as the commissioner of the US Food and Drug Administration by discussing the first year of his second term as the agency’s chief executive and his vision for the future.

Robert Califf in fornt of FDA building
• Source: Shutterstock

Running the US Food and Drug Administration is nothing new for Robert Califf, who took the reins of the agency in February 2022. A cardiologist by trade, Califf also ran the agency in the final year of the Obama administration. But, he noted during a recent fireside chat hosted by the Alliance for a Stronger FDA, that was a more “genteel” time.

In reprising his role as commissioner, not only has Califf had to grapple with a global pandemic, but a more...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By 

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By 

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.